MA27744A1 - Procedes permettant d'empecher la glyconoylation de proteines - Google Patents

Procedes permettant d'empecher la glyconoylation de proteines

Info

Publication number
MA27744A1
MA27744A1 MA28477A MA28477A MA27744A1 MA 27744 A1 MA27744 A1 MA 27744A1 MA 28477 A MA28477 A MA 28477A MA 28477 A MA28477 A MA 28477A MA 27744 A1 MA27744 A1 MA 27744A1
Authority
MA
Morocco
Prior art keywords
preventing
glyconoylation
proteins
methods
microorganisms
Prior art date
Application number
MA28477A
Other languages
English (en)
Inventor
R Gardner Alan
D Sweitzer Thomas
H Taylor Alexander
S Patel Pramathesh
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MA27744A1 publication Critical patent/MA27744A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

"Procédés pour empêcher la gluconoylation de protéines" La présente invention concerne un procédé pour empêcher la glyconoylation de polypeptides produits dans des micro-organismes. (Pas de figure d'abrégé)
MA28477A 2003-03-04 2005-09-05 Procedes permettant d'empecher la glyconoylation de proteines MA27744A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45168603P 2003-03-04 2003-03-04

Publications (1)

Publication Number Publication Date
MA27744A1 true MA27744A1 (fr) 2006-02-01

Family

ID=32962626

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28477A MA27744A1 (fr) 2003-03-04 2005-09-05 Procedes permettant d'empecher la glyconoylation de proteines

Country Status (21)

Country Link
US (2) US8173396B2 (fr)
EP (1) EP1599578B1 (fr)
JP (1) JP2006520609A (fr)
KR (2) KR20050107486A (fr)
CN (2) CN1798836B (fr)
AR (1) AR043719A1 (fr)
AT (1) ATE517985T1 (fr)
AU (2) AU2004217491B2 (fr)
BR (1) BRPI0408023A (fr)
CA (1) CA2517857A1 (fr)
ES (1) ES2369359T3 (fr)
IS (1) IS8029A (fr)
MA (1) MA27744A1 (fr)
MX (1) MXPA05009453A (fr)
MY (1) MY142798A (fr)
NO (1) NO20054532L (fr)
NZ (1) NZ570598A (fr)
RU (2) RU2005130650A (fr)
TW (1) TW200504218A (fr)
WO (1) WO2004078936A2 (fr)
ZA (1) ZA200506709B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2542391A (en) 2015-09-17 2017-03-22 Annexin Pharmaceuticals Ab Process of manufacture
JP7304380B2 (ja) 2021-04-26 2023-07-06 プライムプラネットエナジー&ソリューションズ株式会社 電極集電体および二次電池
WO2025252176A1 (fr) * 2024-06-05 2025-12-11 杭州明德生物医药技术有限公司 Vecteur d'expression et utilisation associée

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643758A (en) 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
DE286239T1 (de) * 1987-03-10 1994-02-24 New England Biolabs Inc Herstellung und Reinigung eines Proteins, das mit einem Bindungsprotein fusioniert ist.
DE4028086A1 (de) 1990-09-05 1992-03-12 Boehringer Mannheim Gmbh Stabile 6-phosphogluconolactonase, verfahren zu deren gewinnung sowie verwendung des enzyms zur bestimmung
US5733762A (en) 1994-04-28 1998-03-31 I.D.M. Immuno-Designed Molecules Complexes of nucleic acid and polymer, their process of preparation and their use for the transfection of cells
US5948681A (en) 1996-08-14 1999-09-07 Children's Hospital Of Philadelphia Non-viral vehicles for use in gene transfer

Also Published As

Publication number Publication date
TW200504218A (en) 2005-02-01
US20090233333A1 (en) 2009-09-17
AU2004217491A1 (en) 2004-09-16
ES2369359T3 (es) 2011-11-29
KR101146483B1 (ko) 2012-05-24
WO2004078936A2 (fr) 2004-09-16
AU2009201136A1 (en) 2009-04-09
CA2517857A1 (fr) 2004-09-16
MY142798A (en) 2010-12-31
CN1798836B (zh) 2011-04-27
JP2006520609A (ja) 2006-09-14
KR20050107486A (ko) 2005-11-11
US20120196372A1 (en) 2012-08-02
ATE517985T1 (de) 2011-08-15
AU2004217491B2 (en) 2009-04-09
WO2004078936A3 (fr) 2006-02-16
BRPI0408023A (pt) 2006-02-14
NO20054532L (no) 2005-11-24
CN1798836A (zh) 2006-07-05
KR20110134514A (ko) 2011-12-14
RU2005130650A (ru) 2006-04-10
NZ570598A (en) 2010-03-26
RU2009149159A (ru) 2011-07-10
EP1599578A2 (fr) 2005-11-30
MXPA05009453A (es) 2005-11-23
EP1599578B1 (fr) 2011-07-27
AR043719A1 (es) 2005-08-10
AU2009201136B2 (en) 2011-06-23
EP1599578A4 (fr) 2007-03-14
US8173396B2 (en) 2012-05-08
IS8029A (is) 2005-09-15
CN101942470A (zh) 2011-01-12
ZA200506709B (en) 2006-08-30
NO20054532D0 (no) 2005-10-03

Similar Documents

Publication Publication Date Title
WO2003104418A3 (fr) Polypeptides reconstitues
EP1943348A4 (fr) Compositions, procedes et kits pour l'amplification d'acides nucleiques
FR2851762B1 (fr) Pince de manutention d'une machine de service de cellules d'electrolyse pour la production d'alumunium
WO2006125954A3 (fr) Systeme de controle de la qualite de l'eau
EP1555324A4 (fr) Procede de defructosylation
TW200636075A (en) Detection of nucleic acid variation by cleavage-amplification method
AU2002343573A1 (en) Methods for detecting genetic haplotypes by interaction with probes
TW200508219A (en) Process for preparing optically pure active compounds
EP1633271A4 (fr) Procede pour blanchir les dents
GB0208041D0 (en) Method of culturing animal cells
IL144247A0 (en) Novel odorant receptors in drosophila
AU2003259222A1 (en) Method of diagnosing alzheimer's disease
TW200510376A (en) Process for preparing (s)-pantoprazole
EP1888108A4 (fr) Souche de silicibacter sp. utile pour la transformation génétique d'algues marines et la préparation d'agents antibiotiques
MA27744A1 (fr) Procedes permettant d'empecher la glyconoylation de proteines
ATE423316T1 (de) Verfahren zum nachweis ungenügender bindung von magnesium an zelluläre membranen zum krankheitsnachweis
AU2003304532A1 (en) Culture specific on-line commerce
AU2002324289A1 (en) Automated process for detecting pathogenic organisms in water
FR2792651A1 (fr) Sequence genomique et polypeptides de pyrococcus abyssi, leurs fragments et leurs utilisations
DE602004031355D1 (de) Neue 1,3-disubstituierte azetidinderivate zur verwendung als liganden des 5ht2a-rezeptors
WO2003106385A3 (fr) Procede de criblage de composes fongitoxiques
AU2003248589A1 (en) Method for determining free thrombin concentration
ATE463468T1 (de) Verwendung von magnesiumphosphat zur wasserenthärtung
DE602006013688D1 (de) Neues verfahren zur herstellung von thoc
FR2851947B1 (fr) Procede d'usinage d'une lentille ophtalmique.